{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:29Z","timestamp":1787003669131,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canadian Institute of Health Research (CIHR) - New Frontiers Research Fund - Exploration","award":["NFRFE-2019-01265"],"award-info":[{"award-number":["NFRFE-2019-01265"]}]},{"name":"Canadian Institute of Health Research (CIHR) - New Frontiers Research Fund - Exploration","award":["NFRFE-2019-01265"],"award-info":[{"award-number":["NFRFE-2019-01265"]}]},{"name":"Canadian Institute of Health Research (CIHR) - New Frontiers Research Fund - Exploration","award":["NFRFE-2019-01265"],"award-info":[{"award-number":["NFRFE-2019-01265"]}]},{"name":"Alberta Cancer Foundation, Canada","award":["RES0019479"],"award-info":[{"award-number":["RES0019479"]}]},{"name":"Alberta Cancer Foundation, Canada","award":["RES0019479"],"award-info":[{"award-number":["RES0019479"]}]},{"name":"Mr. Lube Chair in UroOncology Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14652-2","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T03:45:34Z","timestamp":1754883934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiation activated photodynamic therapy (radioPDT) induces lipid peroxidation and vascular mediated tumor regression of prostate cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Abul Kalam","family":"Azad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Dinakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"9","key":"14652_CR1","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/pharmaceutics13091332","volume":"13","author":"JH Correia","year":"2021","unstructured":"Correia, J. H. et al. Photodynamic therapy review: Principles, photosensitizers, applications, and future directions. Pharmaceutics 13(9), 1332 (2021).","journal-title":"Pharmaceutics"},{"key":"14652_CR2","doi-asserted-by":"publisher","first-page":"686303","DOI":"10.3389\/fchem.2021.686303","volume":"9","author":"G Gunaydin","year":"2021","unstructured":"Gunaydin, G., Gedik, M. E. & Ayan, S. Photodynamic therapy for the treatment and diagnosis of cancer-A review of the current clinical status. Front. Chem. 9, 686303 (2021).","journal-title":"Front. Chem."},{"issue":"3","key":"14652_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pdpdt.2006.12.003","volume":"4","author":"RB Moore","year":"2007","unstructured":"Moore, R. B. et al. A comparison of susceptibility to photodynamic treatment between endothelial and tumor cells in vitro and in vivo. Photodiagnosis Photodyn. Ther. 4(3), 160\u2013169 (2007).","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"3","key":"14652_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41(3), 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"14652_CR5","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","volume":"106","author":"S Kwiatkowski","year":"2018","unstructured":"Kwiatkowski, S. et al. Photodynamic therapy\u2014Mechanisms, photosensitizers and combinations. Biomed. Pharmacother. 106, 1098\u20131107 (2018).","journal-title":"Biomed. Pharmacother."},{"issue":"6B","key":"14652_CR6","first-page":"4271","volume":"21","author":"B Krammer","year":"2001","unstructured":"Krammer, B. Vascular effects of photodynamic therapy. Anticancer Res. 21(6B), 4271\u20134277 (2001).","journal-title":"Anticancer Res."},{"key":"14652_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.863107","volume":"12","author":"L Tan","year":"2022","unstructured":"Tan, L. et al. The role of photodynamic therapy in triggering cell death and facilitating antitumor immunology. Front. Oncol. 12, 863107 (2022).","journal-title":"Front. Oncol."},{"key":"14652_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.691697","volume":"9","author":"G Gunaydin","year":"2021","unstructured":"Gunaydin, G., Gedik, M. E. & Ayan, S. Photodynamic therapy-current limitations and novel approaches. Front. Chem. 9, 691697 (2021).","journal-title":"Front. Chem."},{"key":"14652_CR9","doi-asserted-by":"publisher","first-page":"1250804","DOI":"10.3389\/fbioe.2023.1250804","volume":"11","author":"D Dinakaran","year":"2023","unstructured":"Dinakaran, D. & Wilson, B. C. The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy. Front. Bioeng. Biotechnol. 11, 1250804 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"14652_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.7150\/thno.41578","volume":"10","author":"W Sun","year":"2020","unstructured":"Sun, W. et al. Nanoscintillator-mediated X-ray induced photodynamic therapy for deep-seated tumors: From concept to biomedical applications. Theranostics 10(3), 1296\u20131318 (2020).","journal-title":"Theranostics"},{"issue":"22","key":"14652_CR11","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.3390\/molecules25225398","volume":"25","author":"NJ Collier","year":"2020","unstructured":"Collier, N. J. & Rhodes, L. E. Photodynamic therapy for basal cell carcinoma: The clinical context for future research priorities. Molecules 25(22), 5398 (2020).","journal-title":"Molecules"},{"issue":"2","key":"14652_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pdpdt.2008.05.003","volume":"5","author":"XL Wang","year":"2008","unstructured":"Wang, X. L. et al. Treatment of skin cancer and pre-cancer using topical ALA-PDT\u2013a single hospital experience. Photodiagnosis Photodyn. Ther 5(2), 127\u2013133 (2008).","journal-title":"Photodiagnosis Photodyn. Ther"},{"issue":"6","key":"14652_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251821","volume":"16","author":"AG Mares","year":"2021","unstructured":"Mares, A. G. et al. Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology. PLoS ONE 16(6), e0251821 (2021).","journal-title":"PLoS ONE"},{"issue":"6","key":"14652_CR14","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1021\/acs.nanolett.3c04558","volume":"24","author":"R L\u00f3pez-Rios de Castro","year":"2024","unstructured":"L\u00f3pez-Rios de Castro, R. et al. Therapeutic peptides are preferentially solubilized in specific microenvironments within PEG-PLGA polymer nanoparticles. Nano Lett. 24(6), 2011\u20132017 (2024).","journal-title":"Nano Lett."},{"key":"14652_CR15","doi-asserted-by":"publisher","first-page":"1244709","DOI":"10.3389\/fonc.2023.1244709","volume":"13","author":"AK Azad","year":"2023","unstructured":"Azad, A. K. et al. High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy. Front Oncol. 13, 1244709 (2023).","journal-title":"Front Oncol."},{"key":"14652_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.actbio.2020.09.029","volume":"117","author":"D Dinakaran","year":"2020","unstructured":"Dinakaran, D. et al. PEG-PLGA nanospheres loaded with nanoscintillators and photosensitizers for radiation-activated photodynamic therapy. Acta Biomater. 117, 335\u2013348 (2020).","journal-title":"Acta Biomater."},{"issue":"7","key":"14652_CR17","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3390\/ijms21072302","volume":"21","author":"T Hasegawa","year":"2020","unstructured":"Hasegawa, T. et al. DNA strand break properties of protoporphyrin IX by X-ray irradiation against melanoma. Int. J. Mol. Sci. 21(7), 2302 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"14652_CR18","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1159\/000366383","volume":"34","author":"H Xu","year":"2014","unstructured":"Xu, H. et al. Protoporphyrin IX induces a necrotic cell death in human THP-1 macrophages through activation of reactive oxygen species\/c-Jun N-terminal protein kinase pathway and opening of mitochondrial permeability transition pore. Cell Physiol. Biochem. 34(6), 1835\u20131848 (2014).","journal-title":"Cell Physiol. Biochem."},{"issue":"43","key":"14652_CR19","doi-asserted-by":"publisher","first-page":"36442","DOI":"10.1074\/jbc.M504945200","volume":"280","author":"IM Berquin","year":"2005","unstructured":"Berquin, I. M. et al. Expression signature of the mouse prostate. J. Biol. Chem. 280(43), 36442\u201336451 (2005).","journal-title":"J. Biol. Chem."},{"key":"14652_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4939-2522-3_7","volume":"1292","author":"GY Liou","year":"2015","unstructured":"Liou, G. Y. & Storz, P. Detecting reactive oxygen species by immunohistochemistry. Methods Mol. Biol. 1292, 97\u2013104 (2015).","journal-title":"Methods Mol. Biol."},{"key":"14652_CR21","doi-asserted-by":"crossref","unstructured":"Ito, F., Sono, Y., & Ito, T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: Oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants (Basel) 8(3) (2019).","DOI":"10.3390\/antiox8030072"},{"key":"14652_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-394306-4.00010-1","volume":"295","author":"JO Yoo","year":"2012","unstructured":"Yoo, J. O. & Ha, K. S. New insights into the mechanisms for photodynamic therapy-induced cancer cell death. Int Rev Cell Mol Biol 295, 139\u2013174 (2012).","journal-title":"Int Rev Cell Mol Biol"},{"issue":"9","key":"14652_CR23","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3390\/cancers12092369","volume":"12","author":"T Suzuki","year":"2020","unstructured":"Suzuki, T. et al. Vascular shutdown by photodynamic therapy using talaporfin sodium. Cancers (Basel) 12(9), 2369 (2020).","journal-title":"Cancers (Basel)"},{"key":"14652_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.676342","volume":"9","author":"R Sun","year":"2021","unstructured":"Sun, R. et al. The emerging roles of pericytes in modulating tumor microenvironment. Front Cell Dev. Biol. 9, 676342 (2021).","journal-title":"Front Cell Dev. Biol."},{"issue":"4","key":"14652_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 7(4), 452\u2013464 (2005).","journal-title":"Neuro Oncol."},{"issue":"5","key":"14652_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","volume":"26","author":"RK Jain","year":"2014","unstructured":"Jain, R. K. Antiangiogenesis strategies revisited: From starving tumors to alleviating hypoxia. Cancer Cell 26(5), 605\u2013622 (2014).","journal-title":"Cancer Cell"},{"issue":"2","key":"14652_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0972-3919.130274","volume":"29","author":"B Sanghera","year":"2014","unstructured":"Sanghera, B. et al. FLT PET-CT in evaluation of treatment response. Indian J. Nucl. Med. 29(2), 65\u201373 (2014).","journal-title":"Indian J. Nucl. Med."},{"issue":"27","key":"14652_CR28","doi-asserted-by":"publisher","first-page":"23591","DOI":"10.1021\/acsomega.2c02153","volume":"7","author":"U Gallaga-Gonz\u00e1lez","year":"2022","unstructured":"Gallaga-Gonz\u00e1lez, U. et al. Photoactivation of chemotherapeutic agents with cerenkov radiation for chemo-photodynamic therapy. ACS Omega 7(27), 23591\u201323604 (2022).","journal-title":"ACS Omega"},{"issue":"2","key":"14652_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1615\/JEnvironPatholToxicolOncol.2016016903","volume":"35","author":"BA Hartl","year":"2016","unstructured":"Hartl, B. A. et al. Activating photodynamic therapy in vitro with cerenkov radiation generated from Yttrium-90. J. Environ. Pathol. Toxicol. Oncol. 35(2), 185\u2013192 (2016).","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"2","key":"14652_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ccr.2005.07.014","volume":"8","author":"Z Fuks","year":"2005","unstructured":"Fuks, Z. & Kolesnick, R. Engaging the vascular component of the tumor response. Cancer Cell 8(2), 89\u201391 (2005).","journal-title":"Cancer Cell"},{"issue":"2","key":"14652_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10456-012-9329-2","volume":"16","author":"A El Kaffas","year":"2013","unstructured":"El Kaffas, A., Giles, A. & Czarnota, G. J. Dose-dependent response of tumor vasculature to radiation therapy in combination with Sunitinib depicted by three-dimensional high-frequency power Doppler ultrasound. Angiogenesis 16(2), 443\u2013454 (2013).","journal-title":"Angiogenesis"},{"issue":"3","key":"14652_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1667\/RR2773.1","volume":"177","author":"HJ Park","year":"2012","unstructured":"Park, H. J. et al. Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat. Res. 177(3), 311\u2013327 (2012).","journal-title":"Radiat. Res."},{"issue":"9","key":"14652_CR33","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153221","volume":"23","author":"JR Kaeppler","year":"2022","unstructured":"Kaeppler, J. R. et al. Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models. EMBO Rep. 23(9), e53221 (2022).","journal-title":"EMBO Rep."},{"key":"14652_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jconrel.2023.07.039","volume":"361","author":"B Lahooti","year":"2023","unstructured":"Lahooti, B. et al. Targeting endothelial permeability in the EPR effect. J. Control Release 361, 212\u2013235 (2023).","journal-title":"J. Control Release"},{"issue":"10","key":"14652_CR35","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","volume":"27","author":"Y Nakamura","year":"2016","unstructured":"Nakamura, Y. et al. Nanodrug delivery: Is the enhanced permeability and retention effect sufficient for curing cancer?. Bioconjug. Chem. 27(10), 2225\u20132238 (2016).","journal-title":"Bioconjug. Chem."},{"key":"14652_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114619","volume":"191","author":"HJ Liu","year":"2022","unstructured":"Liu, H. J. & Xu, P. Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor. Adv. Drug Deliv. Rev. 191, 114619 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"14652_CR37","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3171\/2017.6.JNS17860","volume":"129","author":"EA Winkler","year":"2018","unstructured":"Winkler, E. A. et al. Reductions in brain pericytes are associated with arteriovenous malformation vascular instability. J. Neurosurg. 129(6), 1464\u20131474 (2018).","journal-title":"J. Neurosurg."},{"key":"14652_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jocn.2023.07.004","volume":"115","author":"R Maarif","year":"2023","unstructured":"Maarif, R., Kubota, Y. & Chernov, M. F. Early tumor-related hemorrhage after stereotactic radiosurgery of brain metastases: Systematic review of reported cases. J. Clin. Neurosci. 115, 66\u201370 (2023).","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"14652_CR39","first-page":"405","volume":"34","author":"RB Moore","year":"1993","unstructured":"Moore, R. B. et al. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J. Nucl. Med. 34(3), 405\u2013411 (1993).","journal-title":"J. Nucl. Med."},{"issue":"11\u201312","key":"14652_CR40","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/sj.bjc.6690271","volume":"79","author":"VH Fingar","year":"1999","unstructured":"Fingar, V. H. et al. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br. J. Cancer 79(11\u201312), 1702\u20131708 (1999).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"14652_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing, X. et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol. Cancer 18(1), 157 (2019).","journal-title":"Mol. Cancer"},{"key":"14652_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz, B. et al. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl) 3, 83\u201392 (2015).","journal-title":"Hypoxia (Auckl)"},{"issue":"19","key":"14652_CR43","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1158\/1078-0432.CCR-17-0874","volume":"23","author":"S Ueda","year":"2017","unstructured":"Ueda, S. et al. Bevacizumab induces acute hypoxia and cancer progression in patients with refractory breast cancer: Multimodal functional imaging and multiplex cytokine analysis. Clin. Cancer Res. 23(19), 5769\u20135778 (2017).","journal-title":"Clin. Cancer Res."},{"issue":"31","key":"14652_CR44","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41388-018-0259-3","volume":"37","author":"A Chen","year":"2018","unstructured":"Chen, A. et al. Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene 37(31), 4214\u20134225 (2018).","journal-title":"Oncogene"},{"key":"14652_CR45","first-page":"225","volume":"3","author":"VD Courtenay","year":"1978","unstructured":"Courtenay, V. D., Smith, I. E. & Steel, G. G. The effect of misonidazole on the radiation response of clonogenic human pancreatic carcinoma cells. Br. J. Cancer Suppl. 3, 225\u2013227 (1978).","journal-title":"Br. J. Cancer Suppl."},{"key":"14652_CR46","doi-asserted-by":"publisher","first-page":"1335920","DOI":"10.3389\/fimmu.2024.1335920","volume":"15","author":"T Dudzik","year":"2024","unstructured":"Dudzik, T., Doma\u0144ski, I. & Makuch, S. The impact of photodynamic therapy on immune system in cancer\u2014An update. Front. Immunol. 15, 1335920 (2024).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14652-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:09:23Z","timestamp":1757376563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14652-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14652"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14652-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval for animal use protocol was obtained from the Cross Cancer Institute (CCI) Alberta Health Services (AHS) Animal Care Committee Protocol Number AC22262. The study also adhered to the ARRIVE 2.0 guidelines for reporting animal research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}],"article-number":"29299"}}